Rheumatoid arthritis - adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab - review: decision support unit report
Decision support unit report health assessment questionnaire progression
|
Rheumatoid arthritis - adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab - review: decision support unit report
17 March 2015 (1.56 Mb 45 sec) |
This page was last updated: 18 March 2015